BGI Leads $30M Series A Round In Beijing Gene+ Technology
August 26, 2016 — 15:27 CST
This Data Is Locked!
This area is available only to Subscribers.
Chinese genome sequencing firm BGI, previously know as the Beijing Genomics Institute, has led a RMB200 million (US$30 million) series A funding round in Beijing... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals